Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase II trial to study the effectiveness of carboxyamidotriazole in treating
patients who have metastatic kidney cancer. Carboxyamidotriazole may stop the growth of
kidney cancer by stopping blood flow to the tumor